Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqibushenhuoxue decoction is a traditional Chinese herbal formula used in the context of chronic obstructive pulmonary disease (COPD). It is prescribed as an adjunct to conventional therapy (e.g., salmeterol) to potentially improve patient symptoms, quality of life, and reduce dyspnea on exertion, although evidence for direct improvement in lung function parameters (FEV1, FEV1/FVC) is lacking[3][6]. The decoction is not clearly standardized, and its specific ingredient composition is not detailed in the available literature for this particular name. Its formulation is based on traditional Chinese medicine principles to supplement Qi, tonify the kidneys, and activate blood circulation (Yi Qi, Bu Shen, Huo Xue).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yiqibushenhuoxue decoction.